Integrated Device Technology, Inc. (IDTI) grew with the stock adding 0.92% or $0.23 to close at $25.16 on light trading volume of 1.33M compared its three months average trading volume of 1.96M. The San Jose California 95138 based company operating under the Semiconductor – Broad Line industry has been trending up for the last 52 weeks, with the shares price now 1.94% up for the period and up by 6.79% so far this year. With price target of $26.83 and a 55.12% rebound from 52-week low, Integrated Device Technology, Inc. has plenty of upside potential, making it a hold with a view buy.
Integrated Device Technology, Inc. designs, develops, manufactures, and markets a range of semiconductor solutions for the communications, computing, consumer, automotive, and industrial end-markets worldwide. It operates in two segments, Communications; and Computing, Consumer, and Industrial. The Communications segment offers communication timing products, such as clocks and timing solutions; flow-control management devices comprising Serial RapidIO switching solutions; multi-port products; telecommunications products; static random access memory products; first in and first out memories; digital logic products; radio frequency products; and frequency control solutions. The Computing, Consumer, and Industrial segment provides clock generation and distribution products, programmable timing devices, computing timing solutions, high-performance server memory interfaces, PCI Express switching solutions, power management solutions, and signal integrity products, as well as sensing products for mobile, automotive, and industrial solutions. The company markets its products primarily to original equipment manufacturers through various channels, including direct sales, distributors, electronic manufacturing suppliers, and independent sales representatives. Integrated Device Technology, Inc. was founded in 1980 and is headquartered in San Jose, California.
Valley National Bancorp (VLY) had a light trading with around 1.32M shares changing hands compared to its three month average trading volume of 2.2M. The stock traded between $11.6 and $11.89 before closing at the price of $11.64 with 0.95% change on the day. The Wayne New Jersey 07470 based company is currently trading 46.46% above its 52 week low of $8.31 and -3.19% below its 52 week high of $12.14. Both the RSI indicator and target price of and $11.54 respectively, lead us to believe that it could rise over the coming weeks.
Valley National Bancorp operates as the holding company for the Valley National Bank that provides commercial, retail, trust, and investment services. The company operates through Commercial Lending, Consumer Lending, and Investment Management segments. Its deposit products include non-interest bearing, savings, NOW, and money market deposits, as well as certificates of deposit. The companys loan products comprise construction, residential mortgage, home equity, automobile, and floating rate and adjustable rate commercial and industrial loans, as well as fixed rate owner occupied and commercial real estate loans, credit card loans, personal lines of credit, personal loans, and loans secured by cash surrender value of life insurance. It also invests in securities, such as fixed rate investments, federal funds, and interest-bearing deposits with banks; and offers international banking services, such as standby letters of credit, documentary letters of credit and related products, and other ancillary services. In addition, the company provides asset management advisory, trust, and asset-based lending support services; property and casualty, life, health, and title insurance; and health care equipment and other commercial equipment leases, as well as general aviation aircraft loans and commercial equipment leases, and real estate related investments. Further, it offers other banking services comprising automated teller machine, telephone and Internet banking, remote deposit capturing, overdraft, drive-in and night deposit, and safe deposit services. As of December 31, 2015, it operated 227 branches in northern and central New Jersey; the New York City boroughs of Manhattan, Brooklyn, Queens, and Long Island; and southeast and central Florida. The company was founded in 1927 and is headquartered in Wayne, New Jersey.
Zoetis Inc. (ZTS) saw its value increase by 0.66% as the stock gained $0.35 to finish the day at a closing price of $53.74. The stock was lighter in trading and has fluctuated between $38.26-$54.72 per share for the past year. The shares, which traded within a range of $53.35 to $53.88 during the day, are up by 5.54% in the past three months and up by 8.39% over the past six months. It is currently trading 0.84% above its 20 day moving average and 4.66% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $57.4 a share over the next twelve months. The current relative strength index (RSI) reading is 63.23.The technical indicator lead us to believe there will be no major movement any time soon, hold.
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines and vaccines for livestock and companion animals in the United States and internationally. It offers anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; and parasiticides that prevent or eliminate external and internal parasites, such as fleas, ticks, and worms. The company also provides medicated feed additives that offer medicines to livestock; veterinarian solutions for anesthesia, pain management, and the diagnosis of diabetes; and other pharmaceutical products, including pain and sedation, oncology, antiemetic, allergy and dermatology, and reproductive products. In addition, it offers other product categories comprising nutritionals and agribusiness services, as well as products and services in complementary areas consisting of biodevices, diagnostics, and genetics. The company markets its products to veterinarians and livestock producers through its sales representatives, and technical and veterinary operations specialists. Zoetis Inc. was founded in 1952 and is headquartered in Florham Park, New Jersey.